Accidentally Took a Double Dose of Retatrutide?
Retatrutide is an investigational medication in clinical trials. It is not FDA-approved, is not legally compoundable, and is not available through Trimi. Trimi does not offer it and has no plans to. This article is editorial safety coverage for people researching the drug-development pipeline.
This article is general information, not medical advice, and it cannot account for your medications or health history. If you have taken a double dose, contact a licensed clinician or Poison Control at 1-800-222-1222 for guidance specific to your situation.
Related Reading
Sources & References
- Jastreboff AM et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial. NEJM 2023. pubmed.ncbi.nlm.nih.gov/37366315
- U.S. Food and Drug Administration. Human Drug Compounding. fda.gov/drugs/human-drug-compounding
- ClinicalTrials.gov, U.S. National Library of Medicine. clinicaltrials.gov